Vascular dysfunction in diabetes mellitus

Abstract

and cause-specific mortality in a diabetic population. Arch Intern Med 1994; 154: 2473-79. 43 Singer DE, Nathan DM, Anderson KM, et al. Association of HbAIc with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study. Diabetes 1992; 41: 202-08. 44 Park S, Barrett-Connors E, Wingard DL, et al. GHb is a better predictor of cardiovascular disease than fasting or postchallenge plasma glucose in women without diabetes. Diabetes Care 1997; 19: 450-56. 45 Coutinino M, WangY, Gerstein HC,Yusuf S. Continuous relationship of glucose with cardiovacular events in non-diabetic subjects: a mctaregression analysis of 18 studies in 88,000 individuals. Civculation 1996; 94 (suppl 1): I-214. 46 Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H. Coronary-heartdisease risk and impaired glucose tolerance. Lancer 1980; i: 1373-76. 47 Jarrett RJ, McCartney I’, Keen H.The Bedford Survey: ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics. Diabetologia 1982; 22: 79-84. 48 Barrett-Connor E, Wingard DL, Criqui MH, Suarez L. Is borderline fasting hyperglycemia a risk factor for cardiovascular death? J Chronic Dis 1984; 31: 773-79. 49 Meigs JB, Nathan DM, Singer DE, et al. Metabolic abnormalities associated with glucose intolerance extend across the spectrum of prevalent glucose tolerance in 3297 Framingham offspring study subjects. Diabetes 1995; 44 (suppl 1): 5A. 50 Stout R. Insulin and atheroma. Diabetes Care 1990; 13: 631-54. 51 Eschwege E, Richard JL,Thibult N, et al. Coronary heart disease mortality in relation with diabetes, blood glucose, and plasma insulin levels. Harm Metab Res Suppl1985; 15: 41-45. 52 l?y6r& K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care 1979; 2: 131-41. 53 WelbornTA, Wearne K. Coronary heart disease incidence and cardiovascular mortality in Busso 2: 154-60. 54 Curb JD, Pressel SL, Cutler JA, et al. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension.JAAU 1996; 276: 1886-92. 55 Py6rBlP K, PedersenTR, Kjekshus J. The effect of cholesterol lowering with simvastatin on coronary events in diabetic patients with coronary artery disease. Diabetes 1995; 44 (suppl 1): 35A. 56 Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N EnglJ Med 1996; 335: 1001-09. 57 Garcia MJ, McNamara PM, GordonT, Kannel WB. Morbidity and mortality in diabetics in the Framingham population. Diabetes 1974; 23: 105-11. 58 Wilson PW, Kannel WE, Anderson KM. Lipids, glucose intolerance and vascular disease: the Framingham study. MonogrAtherosclerosis 1985: 13: l-l 1.